Business Description
Gossamer Bio is a San Diego-based medical company working to bring a new treatment called seralutinib to patients suffering from pulmonary arterial hypertension, a serious condition affecting the lungs and heart. Their lead drug, taken through inhalation, works by targeting specific proteins in the body that drive the disease and is currently being tested in a large Phase 3 clinical trial. The company holds a licensing agreement that gives them the rights to develop and sell this drug and related compounds. Founded in 2015, Gossamer Bio is focused entirely on turning this promising therapy into an approved treatment option for patients in need.
